Xerimis, Inc. is proud to announce that effective June 1, 2017, Tom Brady has been hired as Director of Business Development, North America. Tom will be responsible for working with sponsor companies throughout North America to satisfy their clinical supply needs.
Tom was previously a Senior Account Executive for Fisher Clinical Services and helped guide global and regional studies to completion for a wide range of sponsor clients. Tom brings a microbiology degree and 20 years of business development experience to the team.
Xerimis, Inc. is a privately held, specialized company providing customized clinical packaging services on a global basis. Serving pharmaceutical, biotechnology and clinical research organizations of all sizes and for each phase of clinical development, Xerimis, Inc. holds true to the traditional approach of building long-term relationships with clients. Whether clients are currently working on an initial Phase I trial, or are in the midst of pivotal Phase III studies, Xerimis, Inc. recognizes that each trial is critical and provides outstanding service and responsiveness to clients so that timelines are met or exceeded.